Psychedelics Stocks to Watch

Aion Therapeutic is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques. It is focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations and other medicinal plants in a legal environment for this type of discovery.

Albert Labs is a Vancouver-based research and drug-development company focused on improving patient access to innovative mental health medications. The company is presently developing a natural psilocybin-based medication for patients with cancer-related distress.

Algernon Pharmaceuticals is a clinical-stage drug-development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough.

ATAI Life Sciences is a clinical-stage biopharma company aiming to transform treatment of mental health disorders.

Awakn Life Sciences is a Canadian biotechnology company with clinical operations centered on researching, developing and delivering psychedelic medicines to treat addiction.

BetterLife Pharma is a biotechnology company engaged in the development and commercialization of psychedelic products for the treatment of mental health disorders in Canada, the US, Australia and the EU.

Biomind Labs is a biotech research and development company aimed at transforming biomedical science knowledge on natural psychotropic plants into novel pharmaceutical drugs and creating nanotech delivery systems for a variety of psychiatric and neurological conditions.

Blackhawk Growth is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. The firm holds a position in the psychedelics market.

Braxia Scientific is a research-driven medical solutions company. The company develops ketamine and psilocybin derivatives and other psychedelic products.

Bright Minds Biosciences is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelics and other serotonergic compounds, while minimizing their side effects; according to Bright Minds, this means its offerings should be superior to first-generation compounds like psilocybin.

Captiva Verde Wellness is a sustainable real estate company that invests in areas like green residential communities, disruptive manufacturing facilities, organic food production and pharmaceutical products.

Clearmind Medicine is a psychedelics, pharma and biotech company that finds and develops novel psychedelics-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder.

COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in mental health. It has developed COMP360, a proprietary high-purity polymorphic crystalline formulation of psilocybin.

Core One Labs is working on psychedelic compounds using novel delivery systems for mental health and neurological disorders.

Creso Pharma is engaged in developing, registering and commercializing pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health.

The firm owns Halucenex Life Sciences, a psychedelics firm based in Canada.

CURE Pharmaceutical Holding is a biopharma company that is developing and manufacturing drug-formulation and drug-delivery technologies in novel dosage forms to improve drug safety, efficacy and patient adherence.

Cybin is focused on progressing psychedelic therapeutics by utilizing proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders, all protected under its ever-growing intellectual property portfolio.

Delic Holdings is a media, ecommerce and event company that operates in the field of psychedelic wellness.

Ehave is a healthcare company engaged in developing a health data platform that integrates with proprietary and third-party assessment and therapeutic digital applications.

Empower Clinics is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care and world-class medical diagnostics laboratories.

Entheon Biomedical is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective dimethyltryptamine-based psychedelic therapeutic products for the purpose of treating addiction and substance-use disorders. Dimethyltryptamine is known as DMT.

Enveric Biosciences is a neuroscience company developing psychedelics-inspired mental health treatments.

Filament Health is a natural psychedelic-drug discovery and extraction technology company. Filament engages in natural extraction technology commercialization utilizing its intellectual property portfolio, in-house GMP facility and Health Canada psilocybin dealer's license.

GH Research is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Lobe Sciences is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, plus devices for the efficient application of medications.

Mind Cure Health is a mental health and wellness company. The company is focused on developing, manufacturing and distributing a branded line of organic functional mushroom extracts.

Mind Medicine is a psychedelic medicine and biotech company that discovers, develops and deploys psychedelics-inspired medicines and therapies to address addiction and mental illness.

Mindset Pharma is a research company using its proprietary platform to develop novel and patentable next-generation psychedelic drug candidates to treat neurological and psychiatric disorders.

Mydecine Innovations Group is a biotech firm with aspirations of developing new mental health therapies based on psychedelic substances.

MYND Life Sciences is a neuro-pharmaceutical drug-development company. The company's mission is to further research the link between depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments utilizing compounds found in psychedelics. Its initial focus is on psilocybin and its various analogs.

NeonMind Biosciences is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions, and to promote health and wellness. One of its divisions focuses on the development of two lead psilocybin-based drug candidates targeting obesity.

Nirvana Life Sciences is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and additional naturally sourced psychedelics to treat pain, opioid dependency and other health problems.

Nova Mentis Life Science is a Canada-based biotechnology company engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders.

Numinus Wellness develops proprietary psychedelics-centered therapeutic products and services through its own laboratory and research and development processes.

Optimi Health is engaged in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector.

Pasithea Therapeutics is a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines, such as psychedelics, cannabis and naturally derived approved drugs.

Pharmala Biotech Holdings is focused on manufacturing and selling MDMA and MDXX active pharmaceutical ingredients for use in clinical research.

PharmaTher Holdings is a specialty life science company that is researching and developing psychedelic pharmaceuticals with the goal of receiving US Food and Drug Administration approval. It is looking to treat mental health concerns, plus neurological and pain disorders.

PsyBio Therapeutics is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental health and neurological disorders.

PSYC is a media-focused company serving the expanding medicinal psychedelics community. Through its media platform, Psychedelic Spotlight, the company has positioned itself at the core of the psychedelics renaissance.

Health supplements company Psyched Wellness creates organic medicinal mushrooms for general body wellness.

Psyence Group is a science-led psychedelics platform led by experts in neurology, neuroscience and drug development. It builds and operates federally licensed commercial psilocybin cultivation and production facilities.

Red Light Holland produces, markets and distributes a premium health and wellness brand of psilocybin truffles within the Netherlands, and sells exotic mushrooms in the US and Canada.

Relmada Therapeutics is a clinical-stage biotech company engaged in developing novel versions of drug products that address areas of high unmet medical needs and treat central nervous system diseases.

Revive Therapeutics is focused on the research, development and commercialization of novel psychedelic and cannabinoid-based life science products, as well as drug repurposing for infectious diseases. Its technology is being developed to address issues like pain, inflammation and wound care.

Seelos Therapeutics is a clinical-stage biotechnology company. The company is focused on developing products that address significant unmet needs in central nervous system disorders and other rare disorders.

SILO Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelics research.

Silo Wellness operates psychedelics clinics and develops legal functional mushroom consumer products. It is focused on developing and introducing psychedelic medicines to reduce trauma and increase performance by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion.

Small Pharma is a neuropharmaceutical company committed to the development of effective therapeutic treatments for mental health disorders.

Tryp Therapeutics is a pharmaceutical company focused on identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. PFN, the company's main development program, is designed to treat neuropsychiatric disorders through the dosing of formulations of synthetic psilocybin.

Universal Ibogaine has a platform of addiction treatment clinics that use ibogaine as a primary modality for the interruption — and ideally cessation — of addictions to primarily opioids such as oxycodone, heroin and fentanyl, as well as alcohol, cocaine and other stimulants.

Wellbeing Digital Sciences is a company focused on ketamine-assisted therapy and psychedelic medicines. It is operating healthcare clinics across North America.

Wesana Health Holdings is an emerging life science company championing the development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain injuries.